Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats

P. Mares, A. Mikulecká, K. Tichá, D. Lojková-Janecková, H. Kubová,

. 2010 ; 51 Suppl 3 () : 24-6.

Language English Country United States

Document type Journal Article

Antagonists of group I of metabotropic glutamate receptors (mGluRs) exhibit anticonvulsant as well as anxiolytic action in adult rodents. Therefore, we started to study these effects in developing rats. Motor seizures induced by pentylenetetrazol (PTZ) and cortical epileptic afterdischarges (CxADs) elicited by electrical stimulation were used in immature rats. High doses of antagonists were needed to demonstrate anticonvulsant effects. Antagonist of mGluR1 AIDA [(R,S)-1-aminoindan-1,5-dicarboxylic acid] suppressed the tonic phase of PTZ-induced generalized tonic-clonic seizures in 7-, 12-, and 18-day-old rats, but not in 25-day-old rats. No significant effect of AIDA against CxADs was found. Antagonists of mGluR5-MPEP [2-methyl-6-(phenylethynyl)-pyridine] and MTEP [3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine] exhibited the same effect against PTZ-induced seizures as AIDA. In addition, they exhibited an anticonvulsant action against CxADs in 12- and 18-day-old rats. No drug compromised motor performance. Anxiolytic action of all three antagonists was demonstrated in light/dark box or in elevated plus maze tests. Homing reaction was used as an age-appropriate test of learning. AIDA did not affect homing, whereas the highest dose of MPEP compromised this behavior in 12- and partially in 18-day-old rats. The three antagonists possess age-dependent anticonvulsant as well as anxiolytic action, with minimal negative side effects.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025614
003      
CZ-PrNML
005      
20121207101458.0
007      
ta
008      
120817s2010 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1111/j.1528-1167.2010.02604.x $2 doi
035    __
$a (PubMed)20618395
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mares, Pavel $u Department of Developmental Epileptology, Institute of Physiology, Academy of Sciences, Prague, Czech Republic. maresp@epilepsy.biomed.cas.cz
245    10
$a Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats / $c P. Mares, A. Mikulecká, K. Tichá, D. Lojková-Janecková, H. Kubová,
520    9_
$a Antagonists of group I of metabotropic glutamate receptors (mGluRs) exhibit anticonvulsant as well as anxiolytic action in adult rodents. Therefore, we started to study these effects in developing rats. Motor seizures induced by pentylenetetrazol (PTZ) and cortical epileptic afterdischarges (CxADs) elicited by electrical stimulation were used in immature rats. High doses of antagonists were needed to demonstrate anticonvulsant effects. Antagonist of mGluR1 AIDA [(R,S)-1-aminoindan-1,5-dicarboxylic acid] suppressed the tonic phase of PTZ-induced generalized tonic-clonic seizures in 7-, 12-, and 18-day-old rats, but not in 25-day-old rats. No significant effect of AIDA against CxADs was found. Antagonists of mGluR5-MPEP [2-methyl-6-(phenylethynyl)-pyridine] and MTEP [3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine] exhibited the same effect against PTZ-induced seizures as AIDA. In addition, they exhibited an anticonvulsant action against CxADs in 12- and 18-day-old rats. No drug compromised motor performance. Anxiolytic action of all three antagonists was demonstrated in light/dark box or in elevated plus maze tests. Homing reaction was used as an age-appropriate test of learning. AIDA did not affect homing, whereas the highest dose of MPEP compromised this behavior in 12- and partially in 18-day-old rats. The three antagonists possess age-dependent anticonvulsant as well as anxiolytic action, with minimal negative side effects.
650    _2
$a věkové faktory $7 D000367
650    _2
$a zvířata $7 D000818
650    _2
$a anxiolytika $x farmakologie $7 D014151
650    _2
$a antikonvulziva $x farmakologie $7 D000927
650    _2
$a elektrická stimulace $7 D004558
650    _2
$a epilepsie $x chemicky indukované $x farmakoterapie $7 D004827
650    _2
$a indany $x farmakologie $x terapeutické užití $7 D007189
650    _2
$a psychomotorický výkon $x účinky léků $7 D011597
650    _2
$a pyridiny $x farmakologie $x terapeutické užití $7 D011725
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a receptory metabotropního glutamátu $x antagonisté a inhibitory $7 D018094
650    _2
$a thiazoly $x farmakologie $x terapeutické užití $7 D013844
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mikulecká, Anna
700    1_
$a Tichá, Katerina
700    1_
$a Lojková-Janecková, Denisa
700    1_
$a Kubová, Hana
773    0_
$w MED00001567 $t Epilepsia $x 1528-1167 $g Roč. 51 Suppl 3(2010), s. 24-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20618395 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121207101532 $b ABA008
999    __
$a ok $b bmc $g 947656 $s 782960
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 51 Suppl 3 $d 24-6 $i 1528-1167 $m Epilepsia $n Epilepsia $x MED00001567
LZP    __
$a Pubmed-20120817/10/03

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...